Saxagliptin amidine impurity is a structurally related synthetic byproduct derived from the parent drug Saxagliptin through amidination of a key amide functionality. It features a substituted pyrrolidone core linked to a guanidine moiety, differing from Saxagliptin by the replacement of an amide group with an amidine functionality. This impurity arises during amidation steps in the synthesis pathway, exhibiting distinct chromatographic and spectroscopic properties. It serves as a critical HPLC reference standard for impurity profiling in Saxagliptin drug substance analysis.
